Prognosis and outcome in CDH1-mutant lobular breast cancer.
作者信息
Corso Giovanni, Veronesi Paolo, Sacchini Virgilio, Galimberti Viviana
机构信息
Division of Breast Cancer Surgery.
School of Medicine, University of Milano, Milan, Italy.
出版信息
Eur J Cancer Prev. 2018 May;27(3):237-238. doi: 10.1097/CEJ.0000000000000405.
Abstract
摘要
相似文献
1
Prognosis and outcome in CDH1-mutant lobular breast cancer.CDH1突变型小叶乳腺癌的预后与结局
Eur J Cancer Prev. 2018 May;27(3):237-238. doi: 10.1097/CEJ.0000000000000405.
2
Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
Eur J Surg Oncol. 2019 Oct;45(10):1760-1761. doi: 10.1016/j.ejso.2019.07.020. Epub 2019 Jul 19.
3
Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.与E-钙黏蛋白种系突变相关的遗传性小叶乳腺癌的临床标准修订
Per Med. 2018 May 1;15(3):153-155. doi: 10.2217/pme-2017-0083. Epub 2018 May 10.
4
CDH1 germline mutations in families with hereditary lobular breast cancer.家族性小叶性乳腺癌中 CDH1 种系突变。
Eur J Cancer Prev. 2022 May 1;31(3):274-278. doi: 10.1097/CEJ.0000000000000688.
5
Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.遗传性乳腺癌伴 E-钙黏蛋白基因缺陷型。
J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21.
6
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
7
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.胚系 CDH1 基因突变在早发性或家族性乳腺小叶癌女性中罕见。
J Med Genet. 2011 Jan;48(1):64-8. doi: 10.1136/jmg.2010.079814. Epub 2010 Oct 4.
8
CDH1 germline mutations and hereditary lobular breast cancer.CDH1基因种系突变与遗传性小叶乳腺癌
Fam Cancer. 2016 Apr;15(2):215-9. doi: 10.1007/s10689-016-9869-5.
9
Germline CDH1 mutations in bilateral lobular carcinoma in situ.双侧乳腺小叶原位癌中的胚系 CDH1 突变。
Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24.
10
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.E-钙黏蛋白在乳腺浸润性小叶癌中的免疫组化表达：与形态学和 CDH1 体细胞改变的相关性。
Hum Pathol. 2020 Aug;102:44-53. doi: 10.1016/j.humpath.2020.06.002. Epub 2020 Jun 26.
引用本文的文献
1
Genomic landscape of breast cancer in elderly patients.老年乳腺癌患者的基因组图谱
NPJ Breast Cancer. 2025 Jul 10;11(1):70. doi: 10.1038/s41523-025-00781-4.
2
Harnessing agent-based frameworks in CellAgentChat to unravel cell-cell interactions from single-cell and spatial transcriptomics.利用CellAgentChat中基于代理的框架从单细胞和空间转录组学中解析细胞间相互作用。
Genome Res. 2025 Jun 2. doi: 10.1101/gr.279771.124.
3
Elacestrant in the treatment landscape of ER-positive, HER2-negative, ESR1-mutated advanced breast cancer: a contemporary narrative review.艾拉司群在雌激素受体阳性、人表皮生长因子受体2阴性、雌激素受体1基因突变的晚期乳腺癌治疗格局中的应用：一篇当代叙述性综述
Ann Med Surg (Lond). 2024 Jun 19;86(8):4624-4633. doi: 10.1097/MS9.0000000000002293. eCollection 2024 Aug.
4
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania.罗马尼亚高危女性的乳腺癌筛查与预防性乳房切除术
Medicina (Kaunas). 2024 Mar 30;60(4):570. doi: 10.3390/medicina60040570.
5
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.miR-125在乳腺癌病因发病机制中的作用：作为鉴别诊断、再生医学及个性化医学挑战中的生物标志物的新角色
Noncoding RNA. 2024 Feb 21;10(2):16. doi: 10.3390/ncrna10020016.
6
Epigenetic regulation of breast cancer metastasis.乳腺癌转移的表观遗传调控。
Cancer Metastasis Rev. 2024 Jun;43(2):597-619. doi: 10.1007/s10555-023-10146-7. Epub 2023 Oct 19.
7
Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro.预处理绒毛膜间质干细胞（CVMSCs）可减少体外乳腺癌细胞系 MDA231 的侵袭表型。
Int J Mol Sci. 2023 May 31;24(11):9569. doi: 10.3390/ijms24119569.
8
Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach.用于监测疾病的组织特异性甲基化生物标志物：一种计算方法。
Int J Mol Sci. 2022 Mar 9;23(6):2959. doi: 10.3390/ijms23062959.
9
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.三阴性乳腺癌：关于流行病学、危险因素、信号通路、治疗及人工智能作用的简要综述
Front Mol Biosci. 2022 Jan 25;9:836417. doi: 10.3389/fmolb.2022.836417. eCollection 2022.
10
Identification of Pathway-Based Biomarkers with Crosstalk Analysis for Overall Survival Risk Prediction in Breast Cancer.基于通路的生物标志物识别及串扰分析用于乳腺癌总生存风险预测
Front Genet. 2021 Oct 21;12:689715. doi: 10.3389/fgene.2021.689715. eCollection 2021.
本文引用的文献
1
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.ERBB2突变与CDH1改变的乳腺浸润性小叶癌患者的预后较差相关。
Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019.
2
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.BRCA基因种系突变对乳腺癌预后的影响：一项系统评价和荟萃分析。
Medicine (Baltimore). 2016 Oct;95(40):e4975. doi: 10.1097/MD.0000000000004975.
3
CDH1 germline mutations and hereditary lobular breast cancer.CDH1基因种系突变与遗传性小叶乳腺癌
Fam Cancer. 2016 Apr;15(2):215-9. doi: 10.1007/s10689-016-9869-5.
4
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
5
E-cadherin germline mutation carriers: clinical management and genetic implications.胚系 E-钙黏蛋白突变携带者：临床管理与遗传影响。
Cancer Metastasis Rev. 2014 Dec;33(4):1081-94. doi: 10.1007/s10555-014-9528-y.
6
Germline CDH1 mutations in bilateral lobular carcinoma in situ.双侧乳腺小叶原位癌中的胚系 CDH1 突变。
Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24.
7
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.CDH1 种系突变与遗传性弥漫性胃癌和小叶乳腺癌综合征：一项多中心研究。
J Med Genet. 2013 Jul;50(7):486-9. doi: 10.1136/jmedgenet-2012-101472. Epub 2013 May 25.
8
Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.E-钙黏蛋白基因的体细胞突变和缺失预示着胃癌患者的生存不良。
J Clin Oncol. 2013 Mar 1;31(7):868-75. doi: 10.1200/JCO.2012.44.4612. Epub 2013 Jan 22.
9
Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer.内质网质量控制：E-钙黏蛋白调控的新机制及其在癌症中的意义
Hum Mol Genet. 2008 Nov 15;17(22):3566-76. doi: 10.1093/hmg/ddn249. Epub 2008 Sep 4.
10
EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.表皮生长因子受体（EGFR）在E-钙黏蛋白突变细胞中调节RhoA-鸟苷三磷酸（RhoA-GTP）依赖性细胞运动。
Hum Mol Genet. 2007 Jul 1;16(13):1639-47. doi: 10.1093/hmg/ddm113. Epub 2007 May 17.
Zotero 插件